Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
Feds sue pharmacy gatekeepers over high insulin costs
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though prescribed for the past 100 years, only three companies supply insulin in the U.S. and much of that is higher-cost branded versions, despite the increasing availability of lower-price biologic options.
Market is Growing at CAGR of 6.0%, Increasing Demand for Cost-Effective Drug Management Solutions Propels Market Growth.Pune, ...
The Pharmacy Benefit Manager Transparency Act of 2022 would ban deceptive unfair pricing schemes and prohibit arbitrary clawbacks of payments made to pharmacies.
Over the past decade, employers, HMOs, health care insurers, and various government entities have turned to pharmacy benefit management companies (PBMs) to help control their drug budgets.
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
A new Idaho law that goes into effect in January reforms pharmacy benefit managers to increase transparency and cut ...
Statistics report on pharmacy benefit managers in the United States This report provides an overview of the pharmacy benefit management (PBM) landscape in the United States. Included within ...
Synergy Medical Associates is a primary care office that provides internal medicine care for patients 15 and older.
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback